中文
OUR RESEARCH AREA
What's monoclonal antibody (mAB)?
monoclonal antibody (mAB) ?A single type of antibody that is directed against a specific epitope (antigen, antigenic determinant) and is produced by a single clone of B cells or a single hybridoma cell line, which is formed by the fusion of a lymphocyte cell with a myeloma cell. Some myeloma cells synthesize single antibodies naturally.


[2008-5-5] Our Company convened the clinical seminar of new tumor drug on 27th April, 2008
[2008-3-27] YI Luan Chao, member of the CPC Central Committee Politburo, secretary of the CPC Central Committee Secretariat and Minister of Organization visited the company on 21st March 2008.
[2008-3-4] the delegation of Penn EMTM program paid a visit to the company
[2008-4-21] Example Project “Industrialization of high technology of humanized monoclonal antibody drug such as Recombinant Human Tumor Necrosis Factor – a Receptor II: IgG Fc Fusion Protein for Injection” passed acceptance check
[2008-1-14] Three SBI titles won by the Company
[2008-1-7] Company’s major projects gained the supports by “863 program” of Science and Technology Ministry
[2008-1-7] Project “YISAIPU - antibody fusion protein for RA treatment” was granted second prize of State Scientific and Technological Award for 2007
[2008-1-2] YISAIPU was nominated by Shanghai Federation of Industrial Economics as “2007 brand of independent creation in the Shanghai equipment manufacturing industry and high technology & new technology industry”
 

[2008-4-21] Example Project “Industrialization of high technology of humanized monoclonal antibody drug such as Recombinant Human Tumor Necrosis Factor – a Receptor II: IgG Fc Fusion Protein for Injection” passed acceptance check
[2008-1-2] YISAIPU was nominated by Shanghai Federation of Industrial Economics as “2007 brand of independent creation in the Shanghai equipment manufacturing industry and high technology & new technology industry”.
[2007-10-13] The meeting about Project
[2006-12-15] The first export products are transported to Colombia
[2006-11-10] Yisaipu is awarded for “national new crucial product”
[2006-10-8] Xinmeige is cognized the new crucial product in shanghai
[2006-9-20] The packing box of a new product attained for appearance design patent certificate issued by State Intellectual Property Office of PRC.
[2005-5-20] Project
 

  Copyright 2002-2006 Shanghai CP Guojian Pharmaceutical Co.,Ltd.